Navigation Links
Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Date:8/20/2007

CARLSBAD, Calif., Aug. 17 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that its CYP450 2C9-VKORC1 panel that it submitted to the FDA for 510(k) clearance late last year, has now been evaluated by the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics (HPCGG).

Warfarin (also called Coumadin) is a drug prescribed to help prevent blood clots. With more than 2 million prescriptions per year, one of the side effects of the drug is an increased risk of bleeding. The FDA re-labeled yesterday the warfarin package insert recommending the testing of multiple genetic variants in two genes namely 2C9 and VKORC1 for safer drug dosing.

"We have completed a successful evaluation of the INFINITI 2C9-VKORC1 panel which has the potential to optimize warfarin dosing and lower the risk of bleeding complications" said Dr. Raju Kucherlapati, Scientific Director of the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics (HPCGG) in Cambridge, Massachusetts. HPCGG is coordinating the "CReating an Optimal Warfarin Nomogram" (CROWN) Trial which is a prospective dosing study utilizing genetic testing to determine the optimal warfarin dose and how this information can be used for clinical care.

"We are pleased to see that through the re-labeling of the warfarin package insert, the FDA has recognized that patients with certain genetic variants may benefit from lower initial dosage thus reducing the risk of major bleeding events" said Ram Vairavan, Senior Vice President at AutoGenomics. He further said "Our expanded panel of genetic variants mentioned in the package insert encompassing African, Asian and other ethnic groups enables same day dosing on our automated multiplexing platform."

About AutoGenomics

AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic pla
'/>"/>

SOURCE AutoGenomics Inc

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2

Related medicine technology :

1. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
2. Bipolar Disorder in Children Difficult to Diagnose, Reports the Harvard Mental Health Letter
3. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
4. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
7. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
8. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
9. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
10. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...e/ -- AMD LASERS just announced that industry lead...pted the position of Medical Director. In his new...g research and development of new soft and hard ti...ontinuing education credits, authoring articles fo... lecturing and seminar engagements. ,, "We are ...
(Date:11/9/2009)...Newswire/ -- LifeNet Health, a leading allograft b...raft Cervical Bio-Implant (VG2C) with Preservon...prietary glycerol-based preservation solution that...ully hydrated state at ambient temperature. This e...lants, doing away with lengthy thawing and rehydra...
(Date:11/9/2009)...Call/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA...mpany,s Bepreve(TM) (bepotastine besilate ophthalm... results were presented in poster sessions at the ...ergy, Asthma & Immunology (ACAAI) in Miami Bea...reatment of Ocular Itching with Bepotastine Besila...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2LifeNet Health Announces First Bio-Implant with New Preservation Technology 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Association of Peruvian Anchovy Producers Pursues MSC Certification 52222 1Association of Peruvian Anchovy Producers Pursues MSC Certification 52222 2Association of Peruvian Anchovy Producers Pursues MSC Certification 52222 3Association of Peruvian Anchovy Producers Pursues MSC Certification 52222 4Association of Peruvian Anchovy Producers Pursues MSC Certification 52222 5Association of Peruvian Anchovy Producers Pursues MSC Certification 52222 6Department of Veterans Affairs Selects Anakam to Provide Trusted Authentication as Part of Its Overall Identity Management Strategy 52217 1Department of Veterans Affairs Selects Anakam to Provide Trusted Authentication as Part of Its Overall Identity Management Strategy 52217 2Department of Veterans Affairs Selects Anakam to Provide Trusted Authentication as Part of Its Overall Identity Management Strategy 52217 3BODY WORLDS Anatomical Exhibitions of Donor Bodies Receives 28 Millionth Visitor 52213 1BODY WORLDS Anatomical Exhibitions of Donor Bodies Receives 28 Millionth Visitor 52213 2
...or Medical Use Approval and Insurance Coverage Var...OCHESTER, N.Y. - April 30, 2007-- Most U.S. adults...nd procedures that can,impact people,s quality of ... fertilization, drugs to treat erectile,dysfunctio... Large,majorities also believe these types of trea...
... N.Y.--(BUSINESS WIRE)--May 1, 2007 - Progenics,Ph... positive,results from the first clinical trial of... infected with the human immunodeficiency,virus (H...ng a,single 5.0 mg/kg dose of PRO 140 achieved an ...n the blood of 98.5% (1.83,log10), with individual...
Other Medicine Technology:Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance 2Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance 3Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance 4Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 2Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 3Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 4Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 5Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 6Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 7
(Date:11/9/2009)... Businesses of all sizes looking to fast...1N1 pandemic have a new resource at their disposal...November 9, 2009 -- Human resource (HR) profession...e efforts for the H1N1 pandemic have a new resourc...squo;s Center for Infectious Disease Research and ...
(Date:11/9/2009)...livers on Election Promise. Now Is Time for Senate...wswire/ -- The following is a statement by Anna Bu...s of struggle and decades of delay, the U.S. House... to pass historic reform legislation to assure eve...o high quality, affordable health care. The House,...
(Date:11/9/2009)...S, Ill., Nov. 9 The House version ...e for America Act , which passed by a vote of 220-...al significant changes to the tax code and differs...pear in any Senate version, requiring extensive re...ued a Special Tax Briefing on the tax provisio...
(Date:11/9/2009)...N, Nov. 9 The Churchill Centre t...or Leadership to J.W. "Bill" Marriott for his life...gressive free market practices and fostering an op...rriott will receive his award at a ceremony and di.... Four Seasons Hotel. ,, "This is a testament ...
(Date:11/9/2009)...eports success with drugs that inhibit estrogen, ...wo drugs used to treat breast cancer and osteoporo...to a new study. , The drugs also cleared precan...nted the onset of cancer in mice with precancerous...and the breast cancer/osteoporosis drug raloxifene...
Breaking Medicine News(10 mins):Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2
... Gay and lesbian civil partnerships (gay marriage)... benefits. Researchers said that such marriage lea...ariety of ways. // Civil partnerships for gay coup...the Journal of Epidemiology and Community Health s...
... Sudden Infant Death is thought to be spurred by t...ists from Bristol, England, have been able to asce...y of Bristol researchers have found certain sets o...ers.' The research team, led by Professor Julia...
... The state government is facing accusation from th...f health services in the state. // Reports are... a relapse within a month of being discharged from...alls, during the previous year. Apparently the gov...
... A new study published in the March 15, 2006 issue...n Cancer Society, says that the risk of a //new ca...ral breast cancer increases to a fair degree in wo...ith hereditary (non-BRCA) breast cancer greatly in...
... It has been proposed by the Jharkhand government ...mdev to exploit the potential of Ayurveda.// The y...y for manufacture and marketing of Ayurvedic medic... Ramdev next week when he arrives here for a yoga ...
... South East Asia has been long considered a wonder...bars, hotel lobbies or restaurants without any inh... the government is seriously thinking about imposi...nt offices, airports and other public venues like ...
Other Medicine News:Health News:Smoking Ban To Be Soon Implemented In South East Asian Bars 2
Onyx® II 9550
FetalSAT™
8600FO MRI
2100 Pulse Oximeter
Medicine Products: